CONFERENCE UPDATE: ISC 2022
Action-CVT study: DOAC therapy as a safer and promising alternative to warfarin in CVT treatment
25 Feb 2022
CONFERENCE UPDATE: ISC 2022
Action-CVT study: DOAC therapy as a safer and promising alternative to warfarin in CVT treatment